Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EXELIXIS, INC. | 50,649 | reported | 27 May 2026 | tx 6+91,546−4,544 |
| Invivyd, Inc. | 50,000 | reported | 23 May 2023 | tx 2+125,000 |
| Xilio Therapeutics, Inc. | 13,200 | reported | 12 Jun 2023 | tx 2+39,600 |
| Akero Therapeutics, Inc. | 0 | reported | 09 Dec 2025 | tx 14+104,398−156,398 |
| OptiNose, Inc. | 0 | reported | 21 May 2025 | tx 10+203,818−13,586 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | EXELIXIS, INC. | 8,367 | 0.00 USD | |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 9,398 | — | |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 26,000 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 15,000 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 15,000 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 13,000 | — | deriv |
| 03 Jun 2025 | GRANT_AWARD | Akero Therapeutics, Inc. | 9,398 | 0.00 USD | |
| 29 May 2025 | GRANT_AWARD | EXELIXIS, INC. | 9,812 | 0.00 USD | |
| 21 May 2025 | SALE | EXELIXIS, INC. | 4,544 | 44.29 USD | |
| 21 May 2025 | OTHER | OptiNose, Inc. | 5,000 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 1,925 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 962 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 3,566 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 2,133 | — | deriv |
| 08 Jun 2024 | GRANT_AWARD | Akero Therapeutics, Inc. | 26,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | OptiNose, Inc. | 75,000 | 0.00 USD | deriv |
| 31 May 2024 | GRANT_AWARD | EXELIXIS, INC. | 18,838 | 0.00 USD | |
| 23 Jun 2023 | GRANT_AWARD | Akero Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 16 Jun 2023 | SALE | Akero Therapeutics, Inc. | 26,000 | 54.67 USD | |
| 16 Jun 2023 | EXERCISE | Akero Therapeutics, Inc. | 26,000 | 25.04 USD | |
| 16 Jun 2023 | EXERCISE | Akero Therapeutics, Inc. | 26,000 | 0.00 USD | deriv |
| 12 Jun 2023 | GRANT_AWARD | Xilio Therapeutics, Inc. | 13,200 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | OptiNose, Inc. | 53,500 | 0.00 USD | deriv |
| 31 May 2023 | GRANT_AWARD | EXELIXIS, INC. | 18,176 | 0.00 USD | |
| 31 May 2023 | GRANT_AWARD | EXELIXIS, INC. | 36,353 | 0.00 USD | deriv |